Home/Journal of the Medical Research Institute/Article Record
Peer-Reviewed Article October 28, 2023

PD-1/PD-L1 AXIS INHIBITORS AS PROMISING STRATEGY FOR MANAGEMENT OF HEPATOCELLULAR CARCINOMA: EXPECTATIONS, BOUNDARIES AND PITFALLS

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Journal of the Medical Research Institute
Publisher: Alexandria University, Medical Research Institute • Egypt • 1110-0133 • 2682-2547
DOI: https://doi.org/10.21608/jmalexu.2023.323222

Abstract

Hepatocellular carcinoma (HCC), the most prevalent primary liver cancer and a leading cause of cancer-related deaths worldwide, has prompted exploration into innovative treatment avenues. Notably, cancer immunotherapy has emerged as a promising strategy, with immune checkpoint inhibitors, specifically targeting the programmed cell death 1 (PD-1) and its ligand (PD-L1), revolutionizing cancer care. PD-1 is a crucial protein in suppressing immune responses and promoting self-tolerance by regulating T-cell function. The PD-1/PD-L1 axis is responsible for immune evasion in cancer cells making it a focal point in cancer therapy. However, despite the potential of PD-1/PD-L1 inhibitors, their clinical utility is hampered by significant immune-related adverse effects. This underscores the urgency to develop novel inhibitors, including small molecules and peptides that target the PD-1/PD-L1 axis to better meet clinical demands. This review focuses on elucidating the biological mechanisms of PD-1/PD-L1 immune checkpoints and their role in both the healthy immune system and the tumor microenvironment. Limitations to this treatment approach include low response rates in certain cancers, immune-related toxicity, and the development of drug resistance. Overcoming these limitations is crucial to expand the use of PD-1/PD-L1 blockade in cancer treatment and improve response rates and survival times for cancer patients

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

3
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.